Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 7th Targeted Radiopharmaceuticals Summit Europe.

C Suite Speakers
KOL Academics & Clinicians
Biopharma Speakers

C Suite Speakers

Andreas Goutopoulos, CEO, ActiThera

Andreas Goutopoulos

Chief Executive Officer & Founder
ActiThera
Fredrik Frejd, CSO Affibody A

Fredrik Frejd

CSO
Affibody AB
Jarrod Longcor, Chief Operating Officer, Cellectar Biosciences Inc.

Jarrod Longcor

Chief Operating Officer
Cellectar Biosciences Inc.
Setareh Shamsili, Chief Executive Officer & Chief Marketing Officer, Coretag

Setareh Shamsili

Chief Executive Officer & Chief Marketing Officer
Coretag
Jeff Cleland, Co-Founder, Iron Fist Therapeutics

Jeff Cleland

Co-Founder
Iron Fist Therapeutics

Josefine Reber

Lab Head, Molecular Imaging & RLT
Novartis AG
Tim Witney, Chief Scientific Officer, Nuclide Therapeutics

Tim Witney

Chief Scientific Officer
Nuclide Therapeutics
Oystein Soug, Chief Executive Officer, OncoOne

Øystein Soug

ceo
Oncoinvent
Michael Thiele, Chief Scientific Officer, OncoOne

Michael Thiele

Chief Scientific Officer
OncoOne
Volker Wagner, Chief Medical Officer, OranoMed

Volker Wagner

Chief Medical Officer
OranoMed
Thijs Spoor, Chief Executive Officer, Perspective Therapeutics

Thijs Spoor

Chief Executive Officer
Perspective Therapeutics
Josie Gayton, Chief Operating Officer, Precirix

Josie Gayton

Chief Operating Officer
Precirix
John Babich, President & Chief Scientific Officer, Ratio Therapeutics

John babich

President & Chief Scientific Officer
Ratio Therapeutics
Abbas Sahili, Chief Executive Officer, Singzyme

Abbas El Sahili

Chief Executive Officer
Singzyme
Sigal Kalmanson, Chief Executive Officer & Co-Founder, Starget Pharma

Sigal Cusnir

CEO
Starget Pharma
Jeremy Paull, Chief Scientific & Regulatory Officer, Starpharma Ltd

Jeremy Paull

Chief Scientific & Regulatory Officer
Starpharma Ltd.

KOL Academics & Clinicians

Harshad Kulkarni, Chief Medical Advisor, Bamf Health

Harshad Kulkarni

Chief Medical Advisor
Bamf Health
Stephen Archibald, Head, Research Department of Imaging Chemistry & Biology, Kings College London

Stephen Archibald

Head, Research Department of Imaging Chemistry & Biology
Kings College London
Tim Witney, Chief Scientific Officer, Nuclide Therapeutics

Tim Witney

Chief Scientific Officer
Nuclide Therapeutics
Arthur Braat, Associate Professor, UMC Utrecht

Arthur Braat

Associate professor 'Translational Nuclear Oncology', Nuclear Medicine Physician
UMC Utrecht
Stuart More, Head of Department - Nuclear Medicine, University of Cape Town

Stuart More

Head of Department - Nuclear Medicine
University of Cape Town

Biopharma Speakers

Guido Wuerth, Head Corporate Development, Radiopharma, Affibody AB

Guido Wuerth

Head of Corporate Development
Affibody AB
Yushuke Kohno, Head of Supply Chain Development, Alpha Fusion Inc.

Yusuke Kohno

Head of Supply Chain Development
Alpha Fusion Inc.
Manuel Sturzbecher Hohne, Head of CMC & Radiopharmaceutical Development, Ariceum Therapeutics

Manuel Sturzbecher-Hoehne

Head of CMC & Radiopharmaceutical Development
Ariceum Therapeutics
Daniel Rossetto, Senior Vice President, Head Of Supply Chain & External Manufacturing, ARTBIO

Daniel Rossetto

SVP Supply Chain & External Manufacturing
ARTBIO
Bala Atilli, Director - Oncology Safety Sciences, AstraZeneca

Bala Nn Rao Attili

Director - Oncology Safety Sciences
AstraZeneca
Mark Fielding, Director - Chemistry, Manufacturing, Controls, Regulatory Affairs & Radiopharmaceuticals, AstraZeneca

Mark Fielding

Director, CMC Regulatory Affairs
AstraZeneca

Sandra Hennig

Regulatory Affairs CMC Strategist
Bayer
Thomas Birger Eden-Jensen, Head of External Supply Management & Radiopharmaceuticals, Bayer

Thomas Birger Edén-Jensen

Head of External Supply Management Radiopharmaceuticals
Bayer
Saudra Uhlenbroich, Director, Bicycle Therapeutics plc

Sandra Uhlenbroich

Director, Discovery Project Lead
Bicycle Therapeutics plc
Kemp Dolliver, Senior Director - Research Analyst, Brookline Capital Markets

Kemp Dolliver

Senior Director - Research Analyst
Brookline Capital Markets
Shaemus Gleason, Executive Vice President, Clarity Pharmaceuticals

Shaemus Gleason

Executive Vice President
Clarity Pharmaceuticals
Angeliki Grammenos, Global Regulatory Affairs Associate Project Lead, Debiopharm

Angeliki Grammenos

Global Regulatory Affairs Associate Project Lead
Debiopharm
Stephen Archibald, Head, Research Department of Imaging Chemistry & Biology, Kings College London

Stephen Archibald

Head, Research Department of Imaging Chemistry & Biology
Kings College London

Daniel Steiner

Senior Vice President, Research & Technology
Molecular Partners AG
Nicoletta Fabiano, Head of RLT Analytical Development Team, Novartis AG

Nicoletta Fabiano

Rlt Analytical Development Team Head
Novartis AG
Vimal Patel, Vice President - Chemistry, Manufacturing & Controls, RadioPharm Theranostics

Vimal Patel

Vice President - Chemistry, Manufacturing & Controls
RadioPharm Theranostics
Levete Meszaros, Head, Clinical Operations & Programs, RadioPharm Theranostics

Levente Meszaros

Vice President, Preclinical & Translational Science
RadioPharm Theranostics
Catello Somma, Partner, Seroba Life Sciences

Catello Somma

Partner
Seroba Life Sciences
Anil Lalwani, Director - Regulatory Chemistry, Manufacturing Controls & MedTech, Telix Pharmaceuticals

Anil Lalwani

Director - Regulatory CMC & MedTech
Telix Pharmaceuticals

Larissa van Golen

Nuclear Medicine Phsyicist
The Netherlands Cancer Institute
Luke Brzozowski, Executive Director, Theranostics and Core Facilities, University Health Network

Luke Brzozowski

Executive Director, Theranostics & Core Facilities
University Health Network
Rebecca Ferrisi, Postdoctoral Researcher, University of Milan

Rebecca Ferirsi

Postdoctoral Researcher
University of Milan
Laboros Meimetis, Assistant Professor - Research, University of Wisconsin, School of Medicine & Public Health

Labros Meimetis

Research Assistant Professor
University of Wisconsin, School of Medicine & Public Health
Brian Santich, Vice President, Research, Y-mAbs Therapeutics Inc

Brian H Santich

Vice President - Research & Development
Y-mAbs Therapeutics Inc
TRP EU Conference Image
Explore the Agenda

Explore the latest industry breakthroughs and get exclusive insights into radiopharmaceutical innovations with our expanded three-track agenda, covering discovery, preclinical research, translational science, clinical progress, CMC, and supply chain strategies.

View Presentations & Speakers
TRP EU Conference Image
Partner With Us

Align yourself with other leading solution providers to ensure your brand remains central to key biopharma deals and decision-making.

Explore Sponsorship Options
TRP EU Conference Image
Join Biopharma Experts

Join the most important conversations with like-minded professionals across all stages of drug development, and build critical connections during dedicated networking sessions designed to foster collaboration and harmonisation throughout the entire development journey.

Register Now